Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus. [electronic resource]
Producer: 20050624Description: 788-95 p. digitalISSN:- 0028-3908
- Animals
- Avoidance Learning -- drug effects
- Basal Ganglia -- drug effects
- Behavior, Animal -- drug effects
- Brain Chemistry -- drug effects
- Calcium Channel Blockers -- pharmacology
- Chromatography, High Pressure Liquid -- methods
- Dose-Response Relationship, Drug
- Drug Interactions
- Extracellular Space -- drug effects
- Glutamic Acid -- metabolism
- Kynurenic Acid -- metabolism
- Kynurenine 3-Monooxygenase
- Male
- Microdialysis -- methods
- Mixed Function Oxygenases -- antagonists & inhibitors
- Potassium Chloride -- pharmacology
- Rats
- Rats, Wistar
- Statistics, Nonparametric
- Sulfonamides -- pharmacology
- Thiazoles -- pharmacology
- Time Factors
- omega-Conotoxin GVIA -- pharmacology
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.